$0.14 Earnings Per Share Expected for MarineMax Inc (HZO) This Quarter

Share on StockTwits

Wall Street analysts predict that MarineMax Inc (NYSE:HZO) will report $0.14 earnings per share for the current quarter, Zacks reports. Six analysts have provided estimates for MarineMax’s earnings, with the highest EPS estimate coming in at $0.20 and the lowest estimate coming in at $0.07. MarineMax reported earnings per share of $0.23 in the same quarter last year, which would suggest a negative year over year growth rate of 39.1%. The firm is scheduled to announce its next quarterly earnings results on Wednesday, January 23rd.

On average, analysts expect that MarineMax will report full year earnings of $1.92 per share for the current year, with EPS estimates ranging from $1.85 to $1.97. For the next financial year, analysts forecast that the business will report earnings of $2.11 per share, with EPS estimates ranging from $1.98 to $2.17. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for MarineMax.

MarineMax (NYSE:HZO) last issued its quarterly earnings results on Tuesday, October 30th. The specialty retailer reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.22. MarineMax had a net margin of 3.34% and a return on equity of 11.97%. The company had revenue of $308.59 million during the quarter, compared to analysts’ expectations of $273.60 million. During the same period last year, the company posted $0.22 EPS. MarineMax’s revenue was up 23.1% on a year-over-year basis.

A number of research analysts recently issued reports on HZO shares. Wedbush lifted their price target on shares of MarineMax from $21.00 to $25.00 and gave the company a “neutral” rating in a research report on Wednesday, October 31st. Raymond James lifted their target price on shares of MarineMax from $24.00 to $28.00 and gave the stock a “strong-buy” rating in a report on Wednesday, October 31st. ValuEngine cut shares of MarineMax from a “buy” rating to a “hold” rating in a report on Friday, November 16th. B. Riley lifted their target price on shares of MarineMax to $30.00 and gave the stock a “buy” rating in a report on Wednesday, October 31st. Finally, Zacks Investment Research raised shares of MarineMax from a “sell” rating to a “hold” rating in a report on Wednesday, September 26th. Four investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. MarineMax presently has an average rating of “Buy” and an average target price of $27.00.

In other news, VP Anthony E. Jr. Cassella sold 8,200 shares of MarineMax stock in a transaction that occurred on Thursday, November 1st. The shares were sold at an average price of $24.01, for a total value of $196,882.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Joseph Allen Watters sold 2,500 shares of MarineMax stock in a transaction that occurred on Monday, October 1st. The stock was sold at an average price of $21.17, for a total transaction of $52,925.00. Following the completion of the sale, the director now owns 62,413 shares of the company’s stock, valued at $1,321,283.21. The disclosure for this sale can be found here. Insiders sold 145,300 shares of company stock valued at $3,545,513 over the last ninety days. Corporate insiders own 5.00% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. BlackRock Inc. grew its stake in shares of MarineMax by 12.6% in the third quarter. BlackRock Inc. now owns 3,503,906 shares of the specialty retailer’s stock worth $74,458,000 after acquiring an additional 393,107 shares during the period. Eagle Asset Management Inc. grew its stake in shares of MarineMax by 4.1% in the third quarter. Eagle Asset Management Inc. now owns 2,895,645 shares of the specialty retailer’s stock worth $61,532,000 after acquiring an additional 113,830 shares during the period. Dimensional Fund Advisors LP grew its stake in shares of MarineMax by 1.1% in the third quarter. Dimensional Fund Advisors LP now owns 2,269,576 shares of the specialty retailer’s stock worth $48,229,000 after acquiring an additional 23,839 shares during the period. Carillon Tower Advisers Inc. grew its stake in shares of MarineMax by 3.8% in the second quarter. Carillon Tower Advisers Inc. now owns 1,861,655 shares of the specialty retailer’s stock worth $35,278,000 after acquiring an additional 67,605 shares during the period. Finally, Macquarie Group Ltd. grew its stake in shares of MarineMax by 4.1% in the third quarter. Macquarie Group Ltd. now owns 1,773,909 shares of the specialty retailer’s stock worth $37,696,000 after acquiring an additional 70,112 shares during the period. Hedge funds and other institutional investors own 91.21% of the company’s stock.

NYSE HZO traded down $1.15 during trading hours on Monday, reaching $19.86. 330,493 shares of the company’s stock traded hands, compared to its average volume of 348,961. MarineMax has a 52-week low of $16.40 and a 52-week high of $26.11. The stock has a market cap of $573.20 million, a P/E ratio of 11.68 and a beta of 0.91.

MarineMax Company Profile

MarineMax, Inc operates as a recreational boat and yacht retailer in the United States. It sells new and used recreational boats, including pleasure boats, such as sport boats, sport cruisers, sport yachts, and other yachts; motor yachts; convertible yachts; pleasure boats; pontoon boats; fishing boats; ski boats; and jet boats.

Featured Article: What is Depreciation?

Get a free copy of the Zacks research report on MarineMax (HZO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for MarineMax (NYSE:HZO)

Receive News & Ratings for MarineMax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MarineMax and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.